In a study of commonly used treatments for multiple sclerosis, both medical and behavioral interventions, and a combination of the two, resulted in significant improvements in fatigue. Researchers say ...

Briumvi’s Phase 3 trial of an at-home injection has completed enrollment, testing an under-the-skin version against IV ...

The experimental drug fenebrutinib worked better than Aubagio, an approved therapy, for reducing relapse rates in MS, new ...

Medicare drug plans are increasingly excluding coverage of new specialty drugs that treat complex conditions like cancers and autoimmune diseases. New research from the USC Schaeffer Center shows how ...

Many women are diagnosed with multiple sclerosis (MS) at an age when they are considering starting a family. What does the disease and its medication mean for the child? To answer this question, a ...

At the recent Consortium of Multiple Sclerosis Centers (CMSC) meeting, Ellen Mowry, MD, of John Hopkins University in Baltimore, presented the Presidential Lecture via livestream. Mowry described two ...

JT Lew, PharmD, MBA, highlights that the primary challenges for patients with multiple sclerosis (MS) in accessing prescribed medications include dealing with the shock of the diagnosis, navigating ...

Rick Blum is meticulous about planning, ordering, and taking the medication he is prescribed to slow the progression of multiple sclerosis, a chronic and incurable neurological disorder that has ...

The biotech's growth portfolio continues to add to its overall top line.

By Mariam Sunny April 29 (Reuters) - Biogen beat first-quarter expectations on Wednesday, as stronger sales of its ...